Regulation of pro-opiomelanocortin (POMC) gene transcription by interleukin-31 via early growth response 1 (EGR-1) in HaCaT keratinocytes

Mol Biol Rep. 2020 Aug;47(8):5953-5962. doi: 10.1007/s11033-020-05668-0. Epub 2020 Jul 23.

Abstract

Pro-opiomelanocortin (POMC) is a large precursor protein of and β-endorphin. POMC expressed in keratinocytes regulates various pathophysiological responses, such as pruritus in atopic dermatitis. Interleukin (IL)-31 is a T helper 2 (Th2)-derived cytokine that functions as a pruritogen, stimulating the sensory neurons in the skin. However, the regulatory mechanism underlying IL-31-induced POMC expression in keratinocytes remains largely unknown. Herein, using a 5'-serial deletion and site-specific mutation constructs of the regulatory region of POMC, we demonstrated that a putative EGR1-binding sequence (EBS) motif in POMC is required for its upregulation by IL-31 in HaCaT keratinocytes. Notably, EGR-1 directly interacted with the EBS motif in POMC. The ectopic expression of EGR-1 stimulated the POMC promoter activity, whereas the knockdown of EGR-1 expression by RNA interference reduced IL-31-induced POMC expression. Furthermore, we observed that three major mitogen-activated protein kinases, ERK, JNK, and p38 kinase, mediated IL-31-induced EGR-1 expression. In summary, our results suggest that EGR-1 trans-activates POMC in response to IL-31 stimulation in HaCaT keratinocytes.

Keywords: Early growth respnse 1; Interleukin-31; Keratinocyte; Mitogen-activated protein kinase; Pro-opiomelanocortin.

MeSH terms

  • Amino Acid Motifs
  • Cell Line, Transformed
  • Early Growth Response Protein 1 / antagonists & inhibitors
  • Early Growth Response Protein 1 / genetics
  • Early Growth Response Protein 1 / physiology*
  • Genes, Reporter
  • Genes, Synthetic
  • Humans
  • Interleukins / pharmacology*
  • Keratinocytes / metabolism*
  • MAP Kinase Signaling System / drug effects
  • Mutagenesis, Site-Directed
  • Point Mutation
  • Pro-Opiomelanocortin / biosynthesis
  • Pro-Opiomelanocortin / genetics*
  • Promoter Regions, Genetic / genetics
  • RNA Interference
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology
  • Real-Time Polymerase Chain Reaction
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Transcription, Genetic / drug effects*
  • Transcriptional Activation
  • Up-Regulation / drug effects

Substances

  • EGR1 protein, human
  • Early Growth Response Protein 1
  • IL31 protein, human
  • Interleukins
  • RNA, Small Interfering
  • Recombinant Proteins
  • Pro-Opiomelanocortin